41 This performance compares favourably with that of troponin for the prediction of myocardial infarction during its clinical implementation period. Neutrophil gelatinase-associated lipocalin has also been evaluated

https://www.selleckchem.com/products/Cilomilast(SB-207499).html as a biomarker of AKI in kidney transplantation. In this setting, AKI due to ischaemia-reperfusion injury can result in delayed graft function, most commonly defined as dialysis requirement within the first post-operative week. Protocol biopsies of kidneys obtained 1 h after vascular anastomosis revealed a significant correlation between NGAL staining intensity in the allograft and the subsequent development of delayed graft function.42 In a prospective multicentre study Pexidartinib supplier of children and adults, urine NGAL levels in samples collected on the day of transplant identified those who subsequently developed delayed graft function (which typically occurred 2–4 days later), with an AUC-ROC of 0.9.43 This has now been confirmed in a larger

multicentre cohort, in which urine NGAL measured within 6 h of kidney transplantation predicted subsequent delayed graft function with an AUC-ROC of 0.81.44 Plasma NGAL measurements have also been correlated with delayed graft function following kidney transplantation from donors after cardiac death.45 Several investigators have examined the role of NGAL as a predictive biomarker of nephrotoxicity following contrast administration.46–50 In a prospective study of children undergoing elective cardiac catheterization with contrast administration, both urine and plasma NGAL predicted contrast-induced nephropathy (defined as a 50% increase in serum creatinine from baseline) within 2 h after contrast administration, with an AUC-ROC of 0.91–0.92.49 In several studies of adults administered contrast, an early rise in both urine (4 h) and plasma (2 h) NGAL were documented, in comparison with a much later increase in plasma cystatin C levels (8–24 h after contrast administration), providing further selleckchem support for NGAL as an early biomarker of contrast nephropathy.46–48

A recent meta-analysis revealed an overall AUC-ROC of 0.894 for prediction of AKI, when NGAL was measured within 6 h after contrast administration and AKI was defined as a >25% increase in serum creatinine.41 Urine and plasma NGAL measurements also represent early biomarkers of AKI in a very heterogeneous paediatric intensive care setting, being able to predict this complication about 2 days before the rise in serum creatinine, with high sensitivity and AUC-ROC of 0.68–0.78.51,52 Several studies have now examined plasma and urine NGAL levels in critically ill adult populations.53–56 Urine NGAL obtained on admission predicted subsequent AKI in multi-trauma patients with an outstanding AUC-ROC of 0.98.